218 related articles for article (PubMed ID: 15618198)
1. Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells.
Lau YE; Rozek A; Scott MG; Goosney DL; Davidson DJ; Hancock RE
Infect Immun; 2005 Jan; 73(1):583-91. PubMed ID: 15618198
[TBL] [Abstract][Full Text] [Related]
2. The human antimicrobial peptide LL-37, but not the mouse ortholog, mCRAMP, can stimulate signaling by poly(I:C) through a FPRL1-dependent pathway.
Singh D; Qi R; Jordan JL; San Mateo L; Kao CC
J Biol Chem; 2013 Mar; 288(12):8258-8268. PubMed ID: 23386607
[TBL] [Abstract][Full Text] [Related]
3. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7.
Nagaoka I; Tamura H; Hirata M
J Immunol; 2006 Mar; 176(5):3044-52. PubMed ID: 16493063
[TBL] [Abstract][Full Text] [Related]
4. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.
De Yang ; Chen Q; Schmidt AP; Anderson GM; Wang JM; Wooters J; Oppenheim JJ; Chertov O
J Exp Med; 2000 Oct; 192(7):1069-74. PubMed ID: 11015447
[TBL] [Abstract][Full Text] [Related]
5. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.
Koczulla R; von Degenfeld G; Kupatt C; Krötz F; Zahler S; Gloe T; Issbrücker K; Unterberger P; Zaiou M; Lebherz C; Karl A; Raake P; Pfosser A; Boekstegers P; Welsch U; Hiemstra PS; Vogelmeier C; Gallo RL; Clauss M; Bals R
J Clin Invest; 2003 Jun; 111(11):1665-72. PubMed ID: 12782669
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37.
Carretero M; Escámez MJ; García M; Duarte B; Holguín A; Retamosa L; Jorcano JL; Río MD; Larcher F
J Invest Dermatol; 2008 Jan; 128(1):223-36. PubMed ID: 17805349
[TBL] [Abstract][Full Text] [Related]
7. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure.
Shaykhiev R; Beisswenger C; Kändler K; Senske J; Püchner A; Damm T; Behr J; Bals R
Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L842-8. PubMed ID: 15964896
[TBL] [Abstract][Full Text] [Related]
8. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface.
Bals R; Wang X; Zasloff M; Wilson JM
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9541-6. PubMed ID: 9689116
[TBL] [Abstract][Full Text] [Related]
9. Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells.
Coffelt SB; Tomchuck SL; Zwezdaryk KJ; Danka ES; Scandurro AB
Mol Cancer Res; 2009 Jun; 7(6):907-15. PubMed ID: 19491199
[TBL] [Abstract][Full Text] [Related]
10. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system.
Barlow PG; Li Y; Wilkinson TS; Bowdish DM; Lau YE; Cosseau C; Haslett C; Simpson AJ; Hancock RE; Davidson DJ
J Leukoc Biol; 2006 Sep; 80(3):509-20. PubMed ID: 16793910
[TBL] [Abstract][Full Text] [Related]
11. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses.
Scott MG; Davidson DJ; Gold MR; Bowdish D; Hancock RE
J Immunol; 2002 Oct; 169(7):3883-91. PubMed ID: 12244186
[TBL] [Abstract][Full Text] [Related]
12. Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial permeability, and prevents epithelial invasion by Pseudomonas aeruginosa.
Byfield FJ; Kowalski M; Cruz K; Leszczyńska K; Namiot A; Savage PB; Bucki R; Janmey PA
J Immunol; 2011 Dec; 187(12):6402-9. PubMed ID: 22095714
[TBL] [Abstract][Full Text] [Related]
13. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor.
Tjabringa GS; Aarbiou J; Ninaber DK; Drijfhout JW; Sørensen OE; Borregaard N; Rabe KF; Hiemstra PS
J Immunol; 2003 Dec; 171(12):6690-6. PubMed ID: 14662872
[TBL] [Abstract][Full Text] [Related]
14. Cathelicidin LL-37 Affects Surface and Intracellular Toll-Like Receptor Expression in Tissue Mast Cells.
Agier J; Brzezińska-Błaszczyk E; Żelechowska P; Wiktorska M; Pietrzak J; Różalska S
J Immunol Res; 2018; 2018():7357162. PubMed ID: 29670923
[TBL] [Abstract][Full Text] [Related]
15. LL-37-induced human osteoblast cytotoxicity and permeability occurs independently of cellular LL-37 uptake through clathrin-mediated endocytosis.
Anders E; Dahl S; Svensson D; Nilsson BO
Biochem Biophys Res Commun; 2018 Jun; 501(1):280-285. PubMed ID: 29729269
[TBL] [Abstract][Full Text] [Related]
16. Intracellular receptor for human host defense peptide LL-37 in monocytes.
Mookherjee N; Lippert DN; Hamill P; Falsafi R; Nijnik A; Kindrachuk J; Pistolic J; Gardy J; Miri P; Naseer M; Foster LJ; Hancock RE
J Immunol; 2009 Aug; 183(4):2688-96. PubMed ID: 19605696
[TBL] [Abstract][Full Text] [Related]
17. The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung.
Tjabringa GS; Rabe KF; Hiemstra PS
Pulm Pharmacol Ther; 2005; 18(5):321-7. PubMed ID: 15939310
[TBL] [Abstract][Full Text] [Related]
18. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis.
Sandgren S; Wittrup A; Cheng F; Jönsson M; Eklund E; Busch S; Belting M
J Biol Chem; 2004 Apr; 279(17):17951-6. PubMed ID: 14963039
[TBL] [Abstract][Full Text] [Related]
19. Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs.
Nijnik A; Pistolic J; Wyatt A; Tam S; Hancock RE
J Immunol; 2009 Nov; 183(9):5788-98. PubMed ID: 19812202
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37.
Lau YE; Bowdish DM; Cosseau C; Hancock RE; Davidson DJ
Am J Respir Cell Mol Biol; 2006 Apr; 34(4):399-409. PubMed ID: 16340000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
